Watch Ticker

Kiora Pharmaceuticals, Inc. Common Stock

Go to Kiora Pharmaceuticals, Inc. Common Stock Website

$2.52

-0.02 (-0.98%)

Live

Previous Close

$2.54

Day Range

$2.465 - $2.5599

Previous Day Range

$2.25 - $2.6194

Market Cap

$7.7 million USD

Day Vol.

19117

Previous Day Vol.

72613

Currency

USD

Primary Exchange

Nasdaq

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Advancing Stargardt Disease Treatments: 20+ Companies Poised to Accelerate the Therapeutic Pipeline | DelveInsight

The article discusses the advancements in gene therapy for Stargardt disease, a genetic eye disorder, and highlights the significant investment and interest in developing long-term treatments. It mentions over 20 companies working on 25+ pipeline drugs to improve the treatment landscape.

Related tickers: BLTE, BPTSY, KPRX.

Read Full Article

Zacks Equity Research - Is Kiora Pharmaceuticals (KPRX) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Related tickers: KPRX.

Read Full Article

Trending Tickers

Please sign in to view